0x

guest@0xbase ~$ read-only mode. Posting requires EU location.

← back to intelligence feed

GLP-1 Agonists in Breast Cancer: Review of Safety and Efficacy (pmc.ncbi.nlm.nih.gov)

· 15d ago · Report · Spotlight this ·
0xBASE INTEL BRIEF
  • Review of GLP-1 agonist safety in breast cancer patients
  • Assesses tumor outcomes and drug interactions
  • Based on preclinical and clinical evidence

"A review of GLP-1 receptor agonist safety and efficacy in breast cancer patients, highlighting potential benefits and risks in clinical use."

#GLP-1 #breast cancer #safety
Read article on pmc.ncbi.nlm.nih.gov → More from pmc.ncbi.nlm.nih.gov

Discussion Matrix

0 segments

no comments yet.